Newron Pharmaceuticals S.p.A. (SWX:NWRN)
Switzerland · Delayed Price · Currency is CHF 9.31
+0.68 (7.88%)
Sep 5, 2025, 5:30 PM CET
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of 185.84 million as of September 5, 2025. Its market cap has increased by 22.96% in one year.
Market Cap
185.84M
Enterprise Value
223.97M
Revenue
48.21M
Ranking
n/a
PE Ratio
12.89
Stock Price
9.31
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has decreased from 309.05M to 185.84M, a decrease of -39.87%. That is a compound annual growth rate of -2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 185.84M | 6.71% |
| Dec 30, 2024 | 174.16M | 97.16% |
| Dec 29, 2023 | 88.33M | 219.35% |
| Dec 30, 2022 | 27.66M | -4.32% |
| Dec 30, 2021 | 28.91M | -24.65% |
| Dec 30, 2020 | 38.37M | -66.14% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 231.65B |
| Novartis AG | 199.55B |
| Lonza Group AG | 40.07B |
| Galderma Group AG | 32.98B |
| Alcon | 31.07B |
| Sandoz Group AG | 21.39B |
| Straumann Holding AG | 14.82B |
| Sonova Holding AG | 13.89B |